Evidence map›Paper›PMID 25064804›Full record

ArticleBiomaterials2014

Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion.

Drew L Sellers, Tae Hee Kim, Christopher W Mount, Suzie H Pun, Philip J Horner

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Recent progress on formulations of hirudin.Pharmaceutical science advances · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Drug delivery to the central nervous system.Nature reviews. Materials · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Drew L SellersDepartment of Neurological Surgery, University of Washington, Seattle, WA 98104, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA. Electronic address: drewfus@uw.edu.
Tae Hee KimDepartment of Bioengineering, University of Washington, Seattle, WA, USA.
Christopher W MountDepartment of Bioengineering, University of Washington, Seattle, WA, USA.
Suzie H PunDepartment of Bioengineering, University of Washington, Seattle, WA, USA.
Philip J HornerDepartment of Neurological Surgery, University of Washington, Seattle, WA 98104, USA; Neurobiology and Behavior Program, Center on Human Development and Disability, University of Washington, Seattle, Washington, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98195, USA.
University of Washington · USNeurological Surgery · US

Funding

Regulation of adult progenitor cells and neural repairR01NS046724 · NINDS · UNIVERSITY OF WASHINGTON · PI HORNER, PHILIP J · 2004 to 2008
$1.7M
NINDS NIH HHS R01 NS046724PHS HHS NSO46724
6 · The paper itself

Abstract

Components of the blood have been proposed as potential therapeutic targets for improving cellular regeneration after injury and neurodegenerative disease. In this work, thrombin is shown to increase endogenous neural progenitor proliferation in the intact murine spinal cord. A local injection of heparin before a spinal cord injury reduces cell proliferation and astrogliogenesis associated with scarring. We sought to create depot-formulations of PLGA microsphere and Pluronic F-127 for sustained local delivery of two thrombin inhibitors, heparin and hirudin. Each hydrogel depot-formulation showed delayed drug release compared to microspheres or hydrogel alone. Animals with a lateral demyelination lesion showed a reduction in CD68+ macrophages when treated with hirudin-loaded PLGA/F-127 gels compared to control and heparin-treated animals. Moreover, hirudin-loaded materials showed an accelerated recovery in coordinated stepping and increased oligodendrocyte densities. Together, these data demonstrate that controlled delivery of hirudin accelerates functional recovery from a demyelination lesion in the spinal cord.

Indexed as

AnimalsAntithrombinsDelayed-Action PreparationsDemyelinating DiseasesFibrinolytic AgentsHeparinHirudinsHirudin TherapyLactic AcidMiceMicrospheresPoloxamerPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerRecovery of FunctionSpinal CordAntithrombinsDelayed-Action PreparationsFibrinolytic AgentsHeparinHirudinsLactic AcidPoloxamerPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerDrug releaseHydrogelPluronicPoly(lactic-co-glycolic) acid microspheresSpinal cordThrombin

Identifiers

PMID25064804
PMCPMC4136545
OpenAlexW2066318078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.